CARRIE SCHMID to Hemiplegia
This is a "connection" page, showing publications CARRIE SCHMID has written about Hemiplegia.
Connection Strength
0.216
-
Precision therapy for a medically actionable ATP1A3 variant from a genomic medicine program in an underserved population. Mol Genet Genomic Med. 2023 Dec; 11(12):e2272.
Score: 0.216